The U.S. Consumer Product Safety Commission (CPSC) recalled more than 400,000 units of four medications, in today's bite-sized hospital and health industry news from Arkansas and Maryland.
- Arkansas: Walmart on Thursday announced that over 36,000 pharmacy technicians at Walmart and Sam's Club will be paid over $20 per hour, effective last week. According to the company, the "significant investment" will allow new employees to be given raises every six months during their first two years of employment, with raises potentially resulting in a $4 per hour raise over four years. (Twenter, Becker's Hospital Review, 6/17)
- Maryland: CPSC on Thursday recalled 407,050 units of four medications at Walgreens and Kroger, citing a lack of childproof packaging. Over 200,000 units of Kroger-brand aspirin and ibuprofen were recalled. Kroger also recalled two of its acetaminophen products, with one having 25,660 units recalled and the other 34,660 units. In addition, Walgreens recalled around 137,300 units of its acetaminophen. For each product, CPSC issued a recall with the warning of "a risk of poisoning if the contents are swallowed by young children." So far, no incidents or injuries have been reported. (Twenter, Becker's Hospital Review, 6/17)
- Maryland: Johns Hopkins Medicine (JHM) announced that Paul Rothman is stepping down as the dean of the medical facility and CEO of JHM. Rothman, who has served in the role since July 1, 2012, will retire July 1—marking a 10-year tenure with many achievements, including pioneering data usage and creating new offices for DEI and well-being. Theodore DeWeese, vice dean for clinical affairs and president of the Johns Hopkins Clinical Practice Association, will serve as the interim dean and CEO. "On a personal level, I have always admired Dean Rothman for his kindness and good humor," said Redonda Miller, president of the Johns Hopkins Hospital. "But professionally, what I will remember most is his ability to cut through all of the noise in a discussion or presentation and hone in on what is important. He is incredibly insightful. He is interested in the substance of what we're doing. That speaks to who he is at his core—a scientist with a love of data and evidence-based discovery." (Gamble, Becker's Hospital Review, 6/17)